University of California, San Diego (UCSD)

La Jolla, California 92103

2 studies enrolling now · 28 studies all time

What they study most

Advanced Cancer, Advanced Non-Small Cell Lung Cancer, Advanced Solid Tumors, Atherosclerosis, Atopic Dermatitis, Breast Cancer, Cardiovascular Diseases, Carotid Artery Diseases, Critical Limb Ischemia, Dementia With Lewy Bodies (DLB), Diabetic Cardiomyopathies, Eczema

Studies at this site

• Parkinson's Foundation PD GENEration Genetic Registry — Recruiting now
• Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT — Recruiting now
• A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old — Completed
• ROADSTER 3 Extended Follow-up Sub-Study — Stopped early
• First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer — Running, not enrolling
• Cenobamate Open-Label Extension Study for YKP3089C025 — Completed
• Study With Various Immunotherapy Treatments in Participants With Lung Cancer — Running, not enrolling
• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia — Completed
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — Completed
• A Retrospective, Multi-center Real-world Study of Steerable Ureteroscopic Renal Evacuation (SURE) Procedure With the CVAC® System — Running, not enrolling
• Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease — Completed
• DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer — Stopped early
• Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN — Withdrawn before enrolling
• Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies — Stopped early
• Extravascular ICD Pivotal Study — Completed
• Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma — Completed
• Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers — Completed
• PDGeneration: Mapping the Future of Parkinson's Disease — Status unconfirmed
• Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies — Completed
• Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors — Paused
• Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy — Running, not enrolling
• Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH — Stopped early
• Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis — Stopped early
• Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed
• Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects — Completed
• Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis — Stopped early
• Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC — Completed
• Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia — Stopped early